JPWO2019204583A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2019204583A5 JPWO2019204583A5 JP2020556835A JP2020556835A JPWO2019204583A5 JP WO2019204583 A5 JPWO2019204583 A5 JP WO2019204583A5 JP 2020556835 A JP2020556835 A JP 2020556835A JP 2020556835 A JP2020556835 A JP 2020556835A JP WO2019204583 A5 JPWO2019204583 A5 JP WO2019204583A5
- Authority
- JP
- Japan
- Prior art keywords
- dry powder
- inhalable dry
- itraconazole
- powder according
- inhalable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000843 powder Substances 0.000 claims 33
- 239000000203 mixture Substances 0.000 claims 15
- VHVPQPYKVGDNFY-TUJWMRSMSA-N 2-[(2S)-butan-2-yl]-4-[4-[4-[4-[[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-1,2,4-triazol-3-one Chemical compound O=C1N([C@@H](C)CC)N=CN1C1=CC=C(N2CCN(CC2)C=2C=CC(OC[C@@H]3O[C@](CN4N=CN=C4)(OC3)C=3C(=CC(Cl)=CC=3)Cl)=CC=2)C=C1 VHVPQPYKVGDNFY-TUJWMRSMSA-N 0.000 claims 13
- 238000009472 formulation Methods 0.000 claims 13
- 229960004130 itraconazole Drugs 0.000 claims 13
- 239000007788 liquid Substances 0.000 claims 13
- 239000002245 particle Substances 0.000 claims 10
- 229940068968 Polysorbate 80 Drugs 0.000 claims 7
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims 7
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 claims 7
- 229920000053 polysorbate 80 Polymers 0.000 claims 7
- 150000001413 amino acids Chemical class 0.000 claims 4
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims 3
- 239000002775 capsule Substances 0.000 claims 3
- PMZURENOXWZQFD-UHFFFAOYSA-L na2so4 Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 claims 3
- 239000003380 propellant Substances 0.000 claims 3
- 239000011780 sodium chloride Substances 0.000 claims 3
- 229910052938 sodium sulfate Inorganic materials 0.000 claims 3
- 235000011152 sodium sulphate Nutrition 0.000 claims 3
- 208000006778 Allergic Bronchopulmonary Aspergillosis Diseases 0.000 claims 2
- 206010006474 Bronchopulmonary aspergillosis allergic Diseases 0.000 claims 2
- -1 cation salt Chemical class 0.000 claims 2
- 229910052751 metal Inorganic materials 0.000 claims 2
- 239000002184 metal Substances 0.000 claims 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims 2
- 159000000000 sodium salts Chemical class 0.000 claims 2
- BLUGYPPOFIHFJS-UUFHNPECSA-N (2S)-N-[(2S)-1-[[(3R,4S,5S)-3-methoxy-1-[(2S)-2-[(1R,2R)-1-methoxy-2-methyl-3-oxo-3-[[(1S)-2-phenyl-1-(1,3-thiazol-2-yl)ethyl]amino]propyl]pyrrolidin-1-yl]-5-methyl-1-oxoheptan-4-yl]-methylamino]-3-methyl-1-oxobutan-2-yl]-3-methyl-2-(methylamino)butanamid Chemical compound CN[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H]([C@@H](C)CC)[C@H](OC)CC(=O)N1CCC[C@H]1[C@H](OC)[C@@H](C)C(=O)N[C@H](C=1SC=CN=1)CC1=CC=CC=C1 BLUGYPPOFIHFJS-UUFHNPECSA-N 0.000 claims 1
- 206010003486 Aspergillus infection Diseases 0.000 claims 1
- 208000006673 Asthma Diseases 0.000 claims 1
- 229940112141 Dry Powder Inhaler Drugs 0.000 claims 1
- 206010017533 Fungal infection Diseases 0.000 claims 1
- 229950008882 Polysorbate Drugs 0.000 claims 1
- 206010038683 Respiratory disease Diseases 0.000 claims 1
- 230000001154 acute Effects 0.000 claims 1
- 150000001298 alcohols Chemical class 0.000 claims 1
- 201000002909 aspergillosis Diseases 0.000 claims 1
- 150000001720 carbohydrates Chemical class 0.000 claims 1
- 235000014633 carbohydrates Nutrition 0.000 claims 1
- 201000003883 cystic fibrosis Diseases 0.000 claims 1
- 239000006185 dispersion Substances 0.000 claims 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 1
- 230000005713 exacerbation Effects 0.000 claims 1
- 239000010419 fine particle Substances 0.000 claims 1
- 159000000003 magnesium salts Chemical class 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 229920000136 polysorbate Polymers 0.000 claims 1
- 210000002345 respiratory system Anatomy 0.000 claims 1
- 238000001694 spray drying Methods 0.000 claims 1
- 239000004094 surface-active agent Substances 0.000 claims 1
- 239000000725 suspension Substances 0.000 claims 1
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201862659479P | 2018-04-18 | 2018-04-18 | |
US62/659,479 | 2018-04-18 | ||
PCT/US2019/028089 WO2019204583A1 (en) | 2018-04-18 | 2019-04-18 | Antifungal formulations for pulmonary administration comprising itraconazole |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2021522161A JP2021522161A (ja) | 2021-08-30 |
JPWO2019204583A5 true JPWO2019204583A5 (ru) | 2022-04-14 |
Family
ID=66429608
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2020556835A Pending JP2021522161A (ja) | 2018-04-18 | 2019-04-18 | イトラコナゾールを含む肺内投与のための抗真菌配合物 |
Country Status (4)
Country | Link |
---|---|
US (1) | US20210145739A1 (ru) |
EP (1) | EP3781125A1 (ru) |
JP (1) | JP2021522161A (ru) |
WO (1) | WO2019204583A1 (ru) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT202000030443A1 (it) * | 2020-12-10 | 2022-06-10 | Zambon Spa | Polvere inalabile comprendente voriconazolo in forma cristallina |
IT202000030437A1 (it) * | 2020-12-10 | 2022-06-10 | Zambon Spa | Metodo per la realizzazione di una polvere inalabile comprendente voriconazolo |
US11471475B1 (en) | 2022-03-08 | 2022-10-18 | Ralph P. Stone | Ophthalmic suspension vehicles and related methods for pharmaceutical ingredient delivery |
WO2024040175A1 (en) | 2022-08-18 | 2024-02-22 | Pulmatrix Operating Company, Inc. | Methods for treating cancer using inhaled angiogenesis inhibitor |
WO2024049982A2 (en) | 2022-08-31 | 2024-03-07 | Pulmatrix Operating Company, Inc. | Methods of using itraconazole dry powders |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4069819A (en) | 1973-04-13 | 1978-01-24 | Societa Farmaceutici S.P.A. | Inhalation device |
US4916134A (en) | 1987-03-25 | 1990-04-10 | Janssen Pharmacuetica N.V. | 4-[4-[4-[4-[[2-(2,4-difluorophenyl)-2-(1H-azolylmethyl)-1,3-dioxolan-4-yl]me]phenyl]-1-piperazinyl]phenyl]triazolones |
IT1228459B (it) | 1989-02-23 | 1991-06-19 | Phidea S R L | Inalatore con svuotamento regolare e completo della capsula. |
EP1343372A2 (en) * | 2000-12-21 | 2003-09-17 | Nektar Therapeutics | Pulmonary delivery of polyene antifungal agents |
US9061027B2 (en) * | 2004-08-27 | 2015-06-23 | Board Of Regents, The University Of Texas System | Enhanced delivery of drug compositions to treat life threatening infections |
EP2227085A4 (en) * | 2007-12-06 | 2013-10-09 | Berg Pharma Llc | INGREDIBLE COMPOSITIONS WITH INCREASED BIOLOGICAL AVAILABILITY |
AU2011320159B2 (en) * | 2010-10-29 | 2016-12-22 | Western University Of Health Sciences | Ternary mixture formulations |
WO2013130767A1 (en) * | 2012-02-29 | 2013-09-06 | Pulmatrix, Inc. | Inhalable dry powders |
EP3525759A1 (en) * | 2016-10-14 | 2019-08-21 | Pulmatrix Operating Company, Inc. | Antifungal dry powders |
-
2019
- 2019-04-18 WO PCT/US2019/028089 patent/WO2019204583A1/en unknown
- 2019-04-18 US US17/048,491 patent/US20210145739A1/en active Pending
- 2019-04-18 EP EP19722383.7A patent/EP3781125A1/en active Pending
- 2019-04-18 JP JP2020556835A patent/JP2021522161A/ja active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2019534270A5 (ru) | ||
Lin et al. | Powder production and particle engineering for dry powder inhaler formulations | |
RU2013118453A (ru) | Катионы одновалентных металлов сухих порошков для ингаляций | |
RU2766086C2 (ru) | Противогрибковые сухие порошки | |
CN103841960B (zh) | 用于吸入的方法和制剂 | |
JP2013540123A5 (ru) | ||
JP2023086774A (ja) | 乾燥粉末配合および使用方法 | |
JP7048642B2 (ja) | 肺、鼻、舌下および/または咽頭への送達に適した、少なくとも1つの生物活性化合物をロードした多孔質シリカ粒子の製造方法 | |
JP2016519160A (ja) | 3つ以上の活性薬剤を呼吸性送達するための組成物、方法、及びシステム | |
JP2006514679A (ja) | トロスピウム含有組成物 | |
JP2021522161A (ja) | イトラコナゾールを含む肺内投与のための抗真菌配合物 | |
US20190167579A1 (en) | Itraconazole dry powders | |
JP6850524B2 (ja) | 吸入用の乾燥粉末製剤 | |
JPWO2019204583A5 (ru) | ||
US20210113461A1 (en) | Methods of Treating Fungal Infections | |
JP2023521396A (ja) | ペラミビル乾燥粉末吸入剤及びその調製方法 | |
CA3085943A1 (en) | Surfactant formulations for inhalation | |
JP2024501372A (ja) | 吸入用医薬組成物 | |
RU2820457C2 (ru) | Способы лечения грибковых инфекций | |
JPWO2020074894A5 (ru) | ||
KR102259824B1 (ko) | 보센탄을 함유한 약학 제제 | |
WO2022122012A1 (zh) | 用于肺部递送的药物组合物 | |
Moon et al. | and Robert O. Williams III1 | |
Moon et al. | Thin-Film Freeze-Drying Process for Versatile Particles for Inhalation Drug Delivery | |
Dongare et al. | An Overview of Recently Published Patents on Pulmonary Drug Delivery Devices |